Immutep Limited
PRRUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.42 | 0.40 | 0.00 | 0.32 |
| FCF Yield | -3.98% | -4.30% | -2.26% | -2.19% |
| EV / EBITDA | -19.48 | -15.05 | -7.76 | -14.39 |
| Quality | ||||
| ROIC | -25.66% | -29.67% | -23.28% | -37.09% |
| Gross Margin | -1,802.84% | -704.74% | -1,119.45% | 52.82% |
| Cash Conversion Ratio | 0.86 | – | – | 0.87 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.24% | -3.62% | -9.48% | -22.44% |
| Free Cash Flow Growth | 16.94% | -167.78% | 18.35% | -17.50% |
| Safety | ||||
| Net Debt / EBITDA | 3.61 | 2.74 | 7.17 | 4.60 |
| Interest Coverage | 0.00 | 0.00 | -2,248.58 | -4,038.97 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -26.90 | 212.45 | 376.80 | -12.09 |